Showing 1191-1200 of 8543 results for "".
Diversity in the Dermatology Workforce: What Can We Do?
https://practicaldermatology.com/topics/practice-management/diversity-in-the-dermatology-workforce-what-can-we-do/23057/Medicine in general lacks workforce diversity. Dermatology fares worse than other specialties. Here’s a closer look at the problem.One-and-Done Tattoo Removal: Is It Possible With Q-switched Technology?
https://practicaldermatology.com/topics/practice-management/one-and-done-tattoo-removal-is-it-possible-with-q-switched-technology/21019/Newer and more powerful nanosecond lasers coupled with improved techniques have greatly improved the ability to clear tattoos faster and treat resistant colors.Expectations: Put it in Writing
https://practicaldermatology.com/topics/practice-management/expectations-put-it-in-writing/20521/Patients who have clear expectations and understand their role in their care and treatment are more engaged, more compliant, and are more likely to have better outcomes. It helps to get it in writing.Can UV Nail Dryers Cause Skin Cancer?
https://practicaldermatology.com/topics/hair-nails/can-uv-nail-dryers-cause-skin-cancer/23898/Alexis Livingston Young, MD, weighs in on the evidence.AGEP Following a New Weight Loss Regimen
https://practicaldermatology.com/youngmd-connect/resident-resource-center/agep-following-a-new-weight-loss-regimen/23719/A 55-Year-Old Man with Erythematous Papules Following a New Weight Loss RegimenClascoterone: A Novel Topical Anti-androgen for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/clascoterone-a-novel-topical-anti-androgen-for-the-treatment-of-acne/23133/For the first time in almost 15 years, a new chemical entity may be coming to the market for the topical treatment of acne vulgaris.Treating Psoriasis in 2015
https://practicaldermatology.com/topics/psoriasis/treating-psoriasis-in-2015/21212/An expert panel of dermatologists gathered at the Maui Derm for Dermatologists 2015 meeting to discuss everything from new therapies and comorbidities to genetic issues related to psoriasis.Weighing the Prospects of Biosimilars
https://practicaldermatology.com/columns/clinical-focus-1/weighing-the-prospects-of-biosimilars/21477/If they are found to be comparable to the “originators,” biosimilar agents may offer patients significant therapeutic benefits as well as cost efficiency.Case Study: A Verrucous Plaque of the Nose
https://practicaldermatology.com/topics/practice-management/case-study-a-verrucous-plaque-of-the-nose/21101/What caused a progressively enlarging mass starting along the nasal septum and extending to the sidewall?We Can Do Better
https://practicaldermatology.com/columns/clinical-focus-1/we-can-do-better/23901/Dermatologists must educate primary care physicians on prevention and screening.